Earnings Call · Q2 FY2021·2021-08-10

Q2 21EPS -6.03%·Rev n/aQ1 21EPS -9.37%·Rev n/aQ4 20EPS +9.38%·Rev n/aQ3 20EPS -35.44%·Rev n/a⚠ consensus missing

BioXcel Therapeutics, Inc. BTAI

Dr. Vimal Mehta — CEO

Richard Steinhart — CFO

−0.2%1d on move date−0.4% vs SPY3d+3.0%5d−4.6%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BTAI calls or request research access.

More BTAI calls Browse calls Request research access